ClinicalTrials.Veeva

Menu

Lateral Sagittal vs Costoclavicular Brachial Plexus Block in Children

A

Ataturk University

Status

Completed

Conditions

Forearm Injuries
Hand Injuries and Disorders

Treatments

Device: Costoclavicular block
Device: Lateral Sagittal block
Drug: Lidocaine and Bupivacaine solution

Study type

Interventional

Funder types

Other

Identifiers

NCT04215614
LS vs Costo BPB Pediatric

Details and patient eligibility

About

Costoclavicular approach has lots of advantages compared to the lateral sagittal approach for infraclavicular brachial plexus block. Although the efficacy of this block has been demonstrated in adults, there are no randomized controlled trials in the literature on the application of pediatric patients. Our aim was to compare the ultrasound-guided infraclavicular and costoclavicular approach in pediatric patients.

Enrollment

60 patients

Sex

All

Ages

5 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologist's physiologic state I-II patients
  • Patients who will undergo hand or forearm surgery

Exclusion criteria

  • Infection in the area to be injected
  • Coagulopathy,
  • Previously known neurological damage

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Group Lateral Sagittal
Active Comparator group
Description:
Ultrasound-Guided lateral sagittal brachial plexus block with 1:1 ratio 2% lidocaine, and 0.5% bupivacaine
Treatment:
Device: Lateral Sagittal block
Drug: Lidocaine and Bupivacaine solution
Group Costoclavicular
Active Comparator group
Description:
Ultrasound-Guided costoclavicular brachial plexus block with 1:1 ratio 2% lidocaine, and 0.5% bupivacaine
Treatment:
Device: Costoclavicular block
Drug: Lidocaine and Bupivacaine solution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems